Full-Time

Medical Science Liaison

Posted on 4/18/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulation technologies for diseases

Biotechnology

Compensation Overview

$172,300 - $253,300Annually

Senior

United States

Required Skills
Communications
Requirements
  • Clinical science degree
  • Advanced degree in medical science (MD, PhD, PharmD, NP, PA)
  • 7+ years MSL experience with therapeutic area expertise highly preferred
Responsibilities
  • Engage in clinically meaningful scientific discussion with thought leaders (TLs) and HCPs
  • Provide scientific presentations and educational programs to HCPs
  • Develop and maintain strong working relationships with thought leaders (TLs) and organizations within the medical community
  • Proactively or responsively support Corcept products via health care professional communication and education
  • Respond to medical inquiries from HCPs in a timely and scientifically accurate manner
  • Generate scientific content intended for healthcare providers
  • Attend and participate in medical conferences and other scientific events
  • Able to critically review scientific literature and provide evidenced-based insights
  • Capture, analyze, synthesize, and report insights and intelligence from the medical and scientific community
  • Support clinical trials, investigator-sponsored studies, scientific communications, publications, clinical and scientific education, advisory boards, and congresses
  • Maintain the highest standards of scientific, clinical, and technical expertise in relevant therapeutic area(s)

Corcept Therapeutics specializes in developing selective glucocorticoid receptor antagonists to address the adverse effects of excess cortisol in a range of diseases, with a primary emphasis on creating a new generation of compounds aimed at mitigating the effects of excess cortisol in various diseases. Their focus is on cortisol modulation technologies for endocrine, metabolic, oncologic, and psychiatric disorders, with a pipeline of over 30 ongoing studies.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

8%

1 year growth

15%

2 year growth

38%